Literature DB >> 29527988

Liver Biopsy Results in Potential Donor Evaluation in Living Related Liver Transplant.

Ebru H Ayvazoglu Soy1, Fatih Boyvat, B Handan Ozdemir, Nihan Haberal, Fatih Hilmioglu, Mehmet Haberal.   

Abstract

OBJECTIVES: The number of living-donor liver transplants has been increasing due to the growing discrepancy between the number of patients on wait lists for liver transplant and the availability of deceased donations. Evaluations of potential liver donors should ensure the safety of the surgical procedure for both the donor and recipient. Liver biopsy is the criterion standard for selecting optimal donors. In this study, we evaluated the importance of preoperative liver biopsy in selecting donor candidates.
MATERIALS AND METHODS: We evaluated the data of 612 living-related liver donor candidates who received liver biopsies between January 2001 and June 2017 at our center.
RESULTS: In the 612 liver donor candidates (328 male, 284 female; age range, 18-69 years), 416 liver biopsies (68%) were reported as normal and 196 liver biopsies (32%) had pathologic findings. Of 196 donors with pathologic findings, 86 (44%) had fatty changes and 24 (12%) had portal inflammation.
CONCLUSIONS: The high rate of pathologic findings in liver biopsy of healthy-appearing donor candidates indicated the importance of liver biopsy in the preoperative evaluation of donors.

Entities:  

Mesh:

Year:  2018        PMID: 29527988     DOI: 10.6002/ect.TOND-TDTD2017.O5

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  2 in total

1.  Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience.

Authors:  Yafei He; Xinyan Zhao; Jimin Liu; Qian Zhang; Liwei Liu; Wei Qu; Ying Liu; Zhigui Zeng; Haiming Zhang; Jidong Jia; Liying Sun; Lin Wei; Zhijun Zhu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

2.  Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.

Authors:  Dieter Broering; Mohamed Shawkat; Ali Albenmousa; Faisal Abaalkhail; Saleh Alabbad; Waleed Al-Hamoudi; Saad Alghamdi; Saleh Alqahthani; Ahmad Jaafari; Roberto Troisi; Khalid Bzeizi
Journal:  PLoS One       Date:  2021-05-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.